Cheiron provides an AI‑powered platform that answers natural‑language biomedical queries by retrieving and summarizing up‑to‑date peer‑reviewed literature. It delivers evidence‑based target suggestions, pathway maps and citation‑rich summaries through a web UI and REST API, with isolated query handling to ensure data confidentiality for pharma, biotech and academic researchers.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biomedical researchers and pharmaceutical developers must manually sift through vast, rapidly expanding scientific literature to identify disease mechanisms, evaluate target viability, and stay current on emerging therapeutic modalities. This process is time‑intensive, prone to missed insights, and hampers the speed of early‑stage drug discovery.
Solution
Cheiron offers an AI‑driven platform that accepts natural‑language biomedical queries and returns concise, evidence‑based answers. The system leverages a large language model fine‑tuned on curated biomedical corpora and integrates real‑time literature retrieval to surface the latest findings. It can propose novel therapeutic targets, summarize recent studies, and map disease pathways, enabling scientists to prioritize hypotheses without extensive manual review. All user inputs are isolated from model training and are not shared with other users, ensuring data confidentiality. Results are delivered through a web interface and an API that can be embedded into existing R&D workflows.
Target Audience
Primary users are pharmaceutical R&D teams, biotech discovery scientists, and academic researchers focused on target identification and early‑stage therapeutic development. The platform also serves computational biology groups that require rapid literature synthesis for hypothesis generation.
Features
- Natural‑language query engine optimized for biomedical terminology and pathway notation
- Real‑time indexing of peer‑reviewed articles (including pre‑prints) with filters for publication date and relevance
- Automated target suggestion module that ranks candidate proteins based on disease‑association scores and druggability metrics
- Summarization of recent research papers with citation extraction and confidence scoring
- Secure, isolated query handling: inputs are excluded from model training and are not stored beyond the session
- RESTful API and SDKs for integration with internal data pipelines, ELN systems, and knowledge‑graph platforms
- Export options for structured data (JSON, CSV) and visual pathway maps compatible with common bioinformatics tools
- Role‑based access control and audit logging to meet GxP compliance requirements